Anpario (ANP) Q4 2025 TU earnings summary

Financial performance highlights

• Revenue reached approximately £47.1m for FY 2025, a 23% increase year-on-year from £38.2m.

• Adjusted EBITDA is expected to be not less than £9.4m, surpassing market expectations and up from £7.0m in 2024.

• Net cash at year-end stood at £12.4m, up from £10.5m the previous year.

Operational and regional performance

• Stronger than expected operating performance in H2 2025 drove higher year-end sales.

• Bio-Vet acquisition contributed fully for the year, with record H2 sales and successful integration.

• Excluding Bio-Vet, broad-based growth was seen across territories, led by Asia, then Americas and Europe.

• IMEA region experienced consolidation after prior high growth, but India sales continued to rise.

Strategic and financial position

• Strong balance sheet supports investment in innovation, global expansion, and further acquisitions.

• Final payment for Bio-Vet acquisition (£0.8m) was completed in Q4.